DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Pfeiffer RF, Gutmann L, Hull KL. the APO302 study investigators. et al
Continued efficacy and safety of subcutaneous apomorphine in
patients with advanced Parkinson's disease.
Parkinsonism Relat Disord 2007; 13: 93-100
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.